I’ll be giving a talk on Finding and Evaluating Market Entry Opportunities at the 13th Annual Pharma Resource Planning & Portfolio Management in Philadelphia, PA on February 6th, 2020. You can…
The post Upcoming Talk: Finding and Evaluating BioPharmace…
Upcoming Talk: Finding and Evaluating BioPharmaceutical Market Entry Opportunities Read Post »
DrugPatentWatch was used in a recent research study on branded drug sales following generic entry. In this paper, authors Jeffrey Fujimoto, Daniel M Tien, Sophie Snyder, Jeppe A Hertz, and…
The post The effect of patent expiration on sales of branded c…
The latest Swiss Biotech annual report focuses on the theme of shaping change. Change is a theme DrugPatentWatch is very familiar with — whether it is a matter of tracking…
The post DrugPatentWatch Headlines Swissbiotech Annual Report appeared first on…
DrugPatentWatch Headlines Swissbiotech Annual Report Read Post »
Here’s a copy of the recent talk on Finding and Evaluating Branded and Generic Market Entry Opportunities. It’s based on the book Make Better Decisions, which distills insights gained from…
The post Finding and Evaluating Branded and Generic Market Ent…
Finding and Evaluating Branded and Generic Market Entry Opportunities Read Post »
Considering switching to DrugPatentWatch? See why others have come to us. Switch to DrugPatentWatch
The post DrugPatentWatch Alternatives appeared first on DrugPatentWatch – Make Better Decisions.
We thought you might be interested in some of the great reviews we’re getting over at software review site G2Crowd. Take a look at a few of the reviews below:…
The post See What Others are Saying About DrugPatentWatch appeared first on DrugPatentWatch …
See What Others are Saying About DrugPatentWatch Read Post »
DrugPatentWatch, a provider of global biopharmaceutical business intelligence, has entered into a partnership with Adis. The partner will enhance Adis’ market-leading platform, bringing together the most relevant information to support…
The post DrugPa…
DrugPatentWatch Partners with Adis: Helping Drug Companies Make Better Decisions Read Post »
Brex is the first corporate credit card specifically for biotech and pharma startups. They provide corporate cards with no founder liability, a best in class rewards program, 10-20x higher spending limits…
The post Brex: The first corporate credit card…
Brex: The first corporate credit card specifically for biotech and pharma startups Read Post »
For readers following the the Biologic Patent Transparency Act, DrugPatentWatch has recently been cited in an article describing the act as “A Solution in Search of a Problem.” In his article,…
The post DrugPatentWatch in the news: The Biologic Patent …
DrugPatentWatch in the news: The Biologic Patent Transparency Act. Read Post »
I will be in Philadelphia on April 11th and 12th and would enjoy the opportunity to meet with current and prospective clients to learn more about your needs. If you…
The post Meet in Philadephia/NJ appeared first on DrugPatentWatch – Make Better Decisi…